On April 12, 2024, Morimatsu (Suzhou) LifeSciences Co., Ltd, a subsidiary of Morimatsu International Holding Co., Ltd ("Morimatsu International", stock code: 2155. HK), held an opening ceremony in Changshu Economic Development Zone, Suzhou. The official opening of the new production base will further release production capacity and continue to empower the quality development of the life and health industry. It will also mark a milestone for Morimatsu in its industrial layout.

Relevant senior government officials, executives of Morimatsu, friends and partners from all walks of life attended the ceremony to witness this critical moment, with attendees including Zhou Qindi, Secretary of Changshu Municipal Party Committee, Qin Meng, Mayor of Changshu, Chen Guodong, Member of Standing Party Committee of Changshu, Matsuhisa Terumoto, Chairman of Morimatsu Group and Morimatsu International Holding Co., Ltd, Nishimatsu Koei, CEO of Morimatsu Group and Morimatsu International, and Tang Weihua, Executive Director and Senior Vice President of Morimatsu Group and Morimatsu International Holding Co., Ltd., and General Manager of Morimatsu (Suzhou) LifeSciences Co., Ltd.

Mr. Tang Weihua, Executive Director and Senior Vice President of Morimatsu Group and Morimatsu International Holding Co., Ltd., and General Manager of Morimatsu (Suzhou) LifeSciences Co., Ltd. delivered a speech:

Morimatsu Suzhou Changshu Plant started construction in July 2022 and after a year and a half, it was successfully put into production with all parties' hard work and support. This new modernized factory, which integrates high automation, intelligence and sustainability, has realized the function of off-site collaboration with Shanghai, Wuhan and Nantong. In this period when the country is accelerating the development of new quality productive forces, Morimatsu is focusing on the resource-rich Yangtze River Delta region, actively exerting the power of scientific and technological innovation, facilitating the digital transformation and upgrading of the manufacturing industry, and continuously shaping the new driving force and new advantages of development to promote the social productivity to achieve a new leap forward.



Mr. Bart Althuizen, customer representative of BUNGE LODERS, delivered a speech:

It is a great honor to witness the historical moment of the official opening of Morimatsu's Changshu plant in Suzhou, solidifying Morimatsu's commitment to providing excellent products and services to more customers. As a global leader in agribusiness, food and ingredients, and biofuels, Bunge Loders is cooperating with Morimatsu for the first time. The core values of both companies are highly matched, and Morimatsu can bring us unlimited possibilities and great success.



Mr. Sam Machour, Chairman of Bio Investments Group, delivered a speech:

Morimatsu has a long development history and has always provided customers with tailor-made, efficient, high-quality solutions with advanced engineering technology and cutting-edge industry ideas for over 30 years. We value the partnership between Morimatsu and the Bio Investments Group helping improve healthcare delivery in Africa and the Middle East. The opening of the new Changshu plant, built to meet the growing global demand, is a milestone in Morimatsu’s development. We wish Morimatsu prosperity and success in the future!



Mr. Qin Meng, Mayor of Changshu, delivered a speech:

The biomedical industry is a sunrise and green industry with the most potential at the moment, and it is also the "No.1 industry" that the government of Suzhou is paying much attention to. As an important area for the layout of Suzhou's biomedical sector, Changshu has built a sound ecology for the prosperous development of life and health industry. Morimatsu has a strong influence and is competitive in life science and technology. The fact that it has chosen to settle in Changshu represents its recognition of and trust in Changshu's business environment and industrial ecology. Changshu will do its best to provide accurate and efficient services in all respects. I sincerely wish that Morimatsu will prosper in its business and continue to promote the industry's development by taking advantage of technological innovation and resource integration.



Mr. Matsuhisa Terumoto, Chairman of Morimatsu Group and Morimatsu International Holding Co., Ltd, delivered a speech:

Senior officials of Changshu City and the Economic Development Zone, partners and customers, thank you for attending this opening ceremony. After the official opening of the Changshu plant of Morimatsu (Suzhou) LifeSciences Co., Ltd, Morimatsu has a total of 4 production bases in China. We will continue to move forward with great efforts and determination by adhering to the ESG strategies of putting people first, actively participating in public welfare and charitable causes, and incorporating environmental protection concepts into our products and services.



The completed project is the first phase project of Morimatsu (Suzhou) LifeSciences Co., Ltd, which covers an area of about 130,000 square meters. This new modern factory, which integrates automation, intelligence, and sustainability, is dedicated to providing excellent core equipment, process systems, and digital-intelligent total factory solutions and services, and will expand capacity to the global pharmaceutical, biopharmaceutical, cosmetic, medical and beauty, daily chemical, and FMCG industries. It also vividly reflects how Morimatsu strengthens its global strategic layout, continuously delivers its full-life-cycle products and services, and builds the Morimatsu brand with international influence and competitiveness.



After the ceremony, the guests visited Morimatsu's showroom and manufacturing workshop. The guests recognized Morimatsu's cultural concept, technical strength, production capacity, and had high expectations for Morimatsu's future development.

Adhering to the spirit of perseverance, Morimatsu roots itself deeply in life science and technology with unlimited potential. We keep forging ahead with determination, uphold the concept of integrated innovation, and always take customers' needs as the driving force to help customers turn their visions into realities, and create value for the industry. Gathering strength to empower the future, Morimatsu will contribute more to society with outstanding performance results!

About Morimatsu LifeSciences

Morimatsu LifeSciences, one of the key business segments of Morimatsu International Holding Co., Ltd. (Morimatsu International, stock code: 2155.HK), mainly consists of Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Pharmadule Morimatsu AB and its subsidiaries, which serves the pharmaceuticals, bio-pharmaceutical, cosmetic medicine, FMCG (cosmetics, baby, women & home Care, health care, fabric & home care, food, beverage, nutraceuticals) and other industries, providing customers with "core equipment+value-added services+digital intelligent overall factory solutions and services" ("MVP Solutions&Services"), focusing on core equipment, stainless steel process systems, disposable process systems, consumables, laboratory solutions, digital and modular factory solutions and services.

As a diversified multinational company, Morimatsu has opened subsidiaries or advanced manufacturing plants in China, Japan, Sweden, United States, India, Italy, Singapore, and has delivered different forms of products and services to more than 40 countries and regions so far, by its global footprint of an efficient and professional team.

Forward-Looking Statements

The information in this press release may include some forward-looking statements. Such statements are essentially susceptible to considerable risks and uncertainties. The use of "predicted", "believed", "forecast", "planned" and/or other similar words/phrases in all statements related to our company is to indicate that the statements are forward-looking ones. Our Company undertakes no obligation to constantly revise such predicted statements.

Forward-looking statements are based on our Company management's current perspectives, assumptions, expectations, estimations, predictions and understanding of future affairs at the time of the making of such statements. Such statements are not guarantees of future development and are susceptible to the impact of risks, uncertainties and other factors; some are beyond the control of our Company and unpredictable. Subject to the influence of future changes and development in our business, competition environment, political, economic, legal and social conditions, the actual outcomes may differ significantly from the information contained in the forward-looking statements.